» Articles » PMID: 33247500

Unexpected Obesity, Rather Than Tumorigenesis, in a Conditional Mouse Model of Mitochondrial Complex II Deficiency

Overview
Journal FASEB J
Specialties Biology
Physiology
Date 2020 Nov 28
PMID 33247500
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in any of the genes encoding the four subunits of succinate dehydrogenase (SDH), a mitochondrial membrane-bound enzyme complex that is involved in both the tricarboxylic acid cycle and the electron transport chain, can lead to a variety of disorders. Recognized conditions with such mutations include Leigh syndrome and hereditary tumors such as pheochromocytoma and paraganglioma (PPGL), renal cell carcinoma, and gastrointestinal stromal tumor. Tumors appear in SDH mutation carriers with dominant inheritance due to loss of heterozygosity in susceptible cells. Here, we describe a mouse model intended to reproduce hereditary PPGL through Cre-mediated loss of SDHC in cells that express tyrosine hydroxylase (TH), a compartment where PPGL is known to originate. We report that while there is modest expansion of TH glomus cells in the carotid body upon SDHC loss, PPGL is not observed in such mice, even in the presence of a conditional dominant negative p53 protein and chronic hypoxia. Instead, we report an unexpected phenotype of nondiabetic obesity beginning at about 20 weeks of age. We hypothesize that this obesity is caused by TH cell loss or altered phenotype in key compartments of the central nervous system responsible for regulating feeding behavior, coupled with metabolic changes due to loss of peripheral catecholamine production.

Citing Articles

Mouse developmental defects, but not paraganglioma tumorigenesis, upon conditional Complex II loss in early Sox10 cells.

Lewis E, Al Khazal F, Wilbanks B, Gades N, Ortega-Saenz P, Lopez-Barneo J FASEB Bioadv. 2024; 6(9):327-336.

PMID: 39399478 PMC: 11467736. DOI: 10.1096/fba.2024-00056.


Tumour immunogenicity goes with the (mitochondrial electron) flow.

Ahmed A, Tait S Mol Oncol. 2024; 18(5):1054-1057.

PMID: 38520041 PMC: 11077003. DOI: 10.1002/1878-0261.13627.


Manipulating mitochondrial electron flow enhances tumor immunogenicity.

Mangalhara K, Varanasi S, Johnson M, Burns M, Rojas G, Esparza Molto P Science. 2023; 381(6664):1316-1323.

PMID: 37733872 PMC: 11034774. DOI: 10.1126/science.abq1053.


An evolving view of complex II-noncanonical complexes, megacomplexes, respiration, signaling, and beyond.

Iverson T, Singh P, Cecchini G J Biol Chem. 2023; 299(6):104761.

PMID: 37119852 PMC: 10238741. DOI: 10.1016/j.jbc.2023.104761.


Succinate dehydrogenase complex subunit C: Role in cellular physiology and disease.

Wang Q, Li M, Zeng N, Zhou Y, Yan J Exp Biol Med (Maywood). 2023; 248(3):263-270.

PMID: 36691338 PMC: 10107392. DOI: 10.1177/15353702221147567.


References
1.
Smith E, Janknecht R, Maher 3rd L . Succinate inhibition of alpha-ketoglutarate-dependent enzymes in a yeast model of paraganglioma. Hum Mol Genet. 2007; 16(24):3136-48. DOI: 10.1093/hmg/ddm275. View

2.
Gill A, Benn D, Chou A, Clarkson A, Muljono A, Meyer-Rochow G . Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes. Hum Pathol. 2010; 41(6):805-14. DOI: 10.1016/j.humpath.2009.12.005. View

3.
Lussey-Lepoutre C, Buffet A, Morin A, Goncalves J, Favier J . Rodent models of pheochromocytoma, parallels in rodent and human tumorigenesis. Cell Tissue Res. 2018; 372(2):379-392. DOI: 10.1007/s00441-018-2797-y. View

4.
van Nederveen F, Dannenberg H, Sleddens H, de Krijger R, Dinjens W . p53 alterations and their relationship to SDHD mutations in parasympathetic paragangliomas. Mod Pathol. 2003; 16(9):849-56. DOI: 10.1097/01.MP.0000084111.03922.4D. View

5.
Bishop T, Ratcliffe P . Genetic basis of oxygen sensing in the carotid body: HIF2α and an isoform switch in cytochrome c oxidase subunit 4. Sci Signal. 2020; 13(615). DOI: 10.1126/scisignal.aba1302. View